- Affiliate Assistant Professor, Global Health
- Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutch
Select from the following:
I’m a Physicist by training, now working in Global Health, where I focus on curing and preventing viral infections by gaining a deeper understanding of pathogenesis. My work involves using mathematical and computational models to explore the complex dynamics driving viral evolution, with the goal of advancing our knowledge in virology and immunology and reducing global burdens of infectious diseases.
My personal webpage: https://dbrvs.org/
- PhD, Dartmouth College
- BA, Colby College
Mayer BT, deCamp AC, Huang Y, Schiffer JT, Gottardo R, Gilbert PB, Reeves DB. Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention. PLoS Comput Biol. 2022 Apr 6;18(4):e1010003. doi: 10.1371/journal.pcbi.1010003. PMID: 35385469; PMCID: PMC9084525.
Reeves DB, Bacchus-Souffan C, Fitch M, Abdel-Mohsen M, Hoh R, Ahn H, Stone M, Hecht F, Martin J, Deeks SG, Hellerstein MK, McCune JM, Schiffer JT, Hunt PW. Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence. Nat Commun. 2023 Oct 2;14(1):6145. doi: 10.1038/s41467-023-41521-1. PMID: 37783718.
Swan DA, Rolland M, Herbeck JT, Schiffer JT, Reeves DB. Evolution during primary HIV infection does not require adaptive immune selection. Proc Natl Acad Sci U S A. 2022 Feb 15;119(7):e2109172119. doi: 10.1073/pnas.2109172119. PMID: 35145025.
Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nat Commun. 2018 Nov 16;9(1):4811. doi: 10.1038/s41467-018-06843-5. PMID: 30446650.